Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-17

Clinical Trial Update: Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1% [Phase 4]

View source ↗

Summary

Phase 4 study comparing Loceryl (amorolfine) nail lacquer 5% to a two-course regimen of urea 40% ointment plus bifonazole cream 1% for treatment of foot dermato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loceryl (Amorolfine)

Snippet

Sponsor: Galderma R&D | Conditions: Foot Dermatoses | Phase 4 | Status: COMPLETED